We assess how well the recently created MRI reconstruction technique, Multi-Resolution Convolutional Neural Network (MRCNN), performs in the core medical vision field (classification). The primary goal of MRCNN is to identify the best k-space undersampling patterns to accelerate the MRI. In this study, we use the Figshare brain tumor dataset for MRI classification with 3064 T1-weighted contrast-enhanced MRI (CE-MRI) over three categories: meningioma, glioma, and pituitary tumors. We apply MRCNN to the dataset, which is a method to reconstruct high-quality images from under-sampled k-space signals. Next, we employ the pre-trained VGG16 model, which is a Deep Neural Network (DNN) based image classifier to the MRCNN restored MRIs to classify the brain tumors. Our experiments showed that in the case of MRCNN restored data, the proposed brain tumor classifier achieved 92.79% classification accuracy for a 10% sampling rate, which is slightly higher than that of SRCNN, MoDL, and Zero-filling methods have 91.89%, 91.89%, and 90.98% respectively. Note that our classifier was trained using the dataset consisting of the images with full sampling and their labels, which can be regarded as a model of the usual human diagnostician. Hence our results would suggest MRCNN is useful for human diagnosis. In conclusion, MRCNN significantly enhances the accuracy of the brain tumor classification system based on the tumor location using under-sampled k-space signals.